Skip to main content

Alzheimer’s Amyloid-Clearing Monoclonal Antibody Drug Lecanemab Shows Positive Results, Poised for FDA Approval

This shows pillsLecanemab, an amyloid-clearing monoclonal antibody drug shows positive results in the treatment of Alzheimer's disease. The drug is now poised for FDA approval early in 2023. Lecanemab slows cognitive decline by 27%.

from Neuroscience News https://ift.tt/GM6Ke0F
Labels:

Comments

Post a Comment

Popular posts from this blog

Menopause Symptoms Reduced by Cold Water Swimming

Cold water swimming significantly eases menopausal symptoms. Surveying 1114 women, with 785 experiencing menopause, researchers found improvements in anxiety, mood swings, low mood, and hot flushes among participants. from Neuroscience News https://ift.tt/9AqHsEa
Post a Comment
Read more

Handwriting Boosts Brain Connectivity and Learning

Handwriting, compared to typing, results in more complex brain connectivity patterns, enhancing learning and memory. This study used EEG data from 36 students to compare brain activity while writing by hand and typing. from Neuroscience News https://ift.tt/0bklQBj
Post a Comment
Read more

More Education, Longer Life: Global Study Reveals Link

A new study reveals that higher education levels significantly reduce the risk of death, regardless of age, sex, location, or background. Researchers found that each additional year of education decreases death risk by two percent, with 18 years of education lowering it by 34 percent. from Neuroscience News https://ift.tt/oeK38Fk
Post a Comment
Read more